Stockreport

Cassava Sciences: New Year, Same Game Of Smoke And Mirrors [Seeking Alpha]

Cassava Sciences, Inc.  (SAVA) 
Last cassava sciences, inc. earnings: 8/12 08:30 am Check Earnings Report
PDF The company's research and development expenses increased to $89.4m in 2023. Cassava's CEO remains optimistic about the Phase 3 program of its drug candidate, simufil [Read more]